๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Agglomerate Strength and Dispersion of Salmeterol Xinafoate from Powder Mixtures for Inhalation

โœ Scribed by Handoko Adi; Ian Larson; Herbert Chiou; Paul Young; Daniela Traini; Peter Stewart

Book ID
106492897
Publisher
Springer US
Year
2006
Tongue
English
Weight
772 KB
Volume
23
Category
Article
ISSN
0724-8741

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Dry powder formulations for inhalation o
Dry powder formulations for inhalation of fluticasone propionate and salmeterol xinafoate microcrystals
โœ Darragh Murnane; Gary P. Martin; Christopher Marriott ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 307 KB

Direct crystallization of active pharmaceutical ingredient (API) particles in the inhalable size range of 1-6 microm may overcome surface energization resulting from micronization. The aerosolization of fluticasone propionate (FP) and salmeterol xinafoate (SX) microcrystals produced by aqueous cryst

Effect of carrier size on the dispersion
Effect of carrier size on the dispersion of salmeterol xinafoate from interactive mixtures
โœ Nazrul Islam; Peter Stewart; Ian Larson; Patrick Hartley ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 209 KB

The objective of this study was to determine the influence of lactose carrier size on drug dispersion of salmeterol xinafoate (SX) from interactive mixtures. SX dispersion was measured by using the fine particle fractions determined by a twin stage impinger attached to a Rotahaler 1 . The particle s